HIGHLIGHTS
- who: January and collaborators from the Syracuse University, United States have published the paper: Strategies to counteract adverse remodeling of vascular graft: A 3D view of current graft innovations, in the Journal: (JOURNAL)
- what: The authors focused a literature review on those published in recent years and placed them in the landscape of graft innovations in translation, scaffold and cell technologies.
- how: Showed that one patient maintained primary patency and 10 maintained secondary patency.
SUMMARY
Selective TEVGs have gradually progressed into clinical trials, for both adult patients (Lawson et_al . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.